Mrv1652306031608572D 17 18 0 0 0 0 999 V2000 -0.7145 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0000 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 -2.8875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.8250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.0000 -1.6500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.2534 -2.5038 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.8661 -3.1746 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.1018 1.9659 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.3272 1.9659 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 -2.4750 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 1.2375 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 3 1 1 0 0 0 0 4 2 1 0 0 0 0 8 5 1 0 0 0 0 9 6 1 0 0 0 0 10 1 1 0 0 0 0 10 5 1 0 0 0 0 10 7 1 0 0 0 0 11 2 1 0 0 0 0 11 6 1 0 0 0 0 11 7 1 0 0 0 0 16 3 1 0 0 0 0 16 8 1 0 0 0 0 16 12 2 0 0 0 0 16 13 2 0 0 0 0 17 4 1 0 0 0 0 17 9 1 0 0 0 0 17 14 2 0 0 0 0 17 15 2 0 0 0 0 M END > DB12473 > drugbank > O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1 > InChI=1S/C7H16N4O4S2/c12-16(13)3-1-10(5-8-16)7-11-2-4-17(14,15)9-6-11/h8-9H,1-7H2 > AJKIRUJIDFJUKJ-UHFFFAOYSA-N > C7H16N4O4S2 > 284.35 > 284.061297359 > 6 > 33 > 26.079476660002886 > 1 > 2 > 0 > 0 > 4-[(1,1-dioxo-1lambda6,2,4-thiadiazinan-4-yl)methyl]-1lambda6,2,4-thiadiazinane-1,1-dione > -2.07 > -2.465751423666666 > -1.25 > 0 > 2 > 0 > 11.133652621075884 > 10.531590018011977 > 1.973166023229091 > 98.82 > 60.734500000000004 > 2 > 1 > 1.62e+01 g/l > 4-[(1,1-dioxo-1lambda6,2,4-thiadiazinan-4-yl)methyl]-1lambda6,2,4-thiadiazinane-1,1-dione > 0 > DB12473 > approved; investigational > Taurolidine > Taurolidine > Defencath $$$$